HomeServe Establishes Joint Venture in Japan as Part of Global Partnership Strategy
HomeServe plc ("HomeServe"), the international home repairs and improvements business, has signed an agreement with Mitsubishi Corporation (“MC”) to establish a joint venture (“JV”) in Japan.
To be called HomeServe Japan Corporation, the joint venture will be 50:50 owned by HomeServe and Mitsubishi Corporation. HomeServe Japan Corporation will build a business to provide home emergency and repair services in electrics, plumbing, gas, heating, ventilation and air conditioning. The business will be based on a membership model and will also offer on-demand services to residential customers.
Japan is the world’s third largest economy with 53 million residential households. Recent liberalisation of the gas and electricity markets, together with access to the water market for private concessions, has created a positive environment for HomeServe’s utility branded home assistance model.
The move is part of HomeServe’s global partnership approach to provide successful strategies for utility companies to improve their connection with customers and strengthen and lengthen their relationships.
Utility companies are facing unprecedented challenges. Regulatory change, new innovative players, higher consumer expectations and rapidly evolving technology are putting pressure on revenue and encouraging customer churn.
According to Stephen Phillips, HomeServe’s Global CEO of International Business Development: “Utilities need to move beyond providing basic services and re-evaluate their business models to embrace the opportunities which are opening up in this new landscape. Customers have become used to effortless online experiences in areas such as retailing and smart tech, and now want the same convenience from their utility providers.
“Customers want providers to help them monitor, manage and maintain their homes. By offering their customers targeted, value added products that can be integrated into larger smart home systems, utilities have the opportunity to become more relevant in their customers’ lives.”
Home services propositions and technologies can support a utility’s positioning as a one stop shop for home and energy management solutions. Research shows that customers view their utility as the logical provider of such services, and that such offerings have a positive impact on customer relationships.
In HomeServe USA’s white paper, ‘Natural Gas Utilities: Securing the Future, June 2017’, analysis of utility customers who bought a home assistance plan showed an increase in customer satisfaction of more than 60% amongst electricity customers after enrolling. Enrolled gas customers were more than 75% happier with their provider than those who were not signed up.
The paper also links customer satisfaction to a better return on equity (ROE) and increased profitability. On average top quartile utilities earned 10.7% ROE, whereas bottom quartile utilities earned 10.1%. Similarly, electric utilities in the top quartile of customer satisfaction typically report profits 3-4% higher than utilities in the three lower quartiles.
Other research (Eneco btg.org 2015 and Centrica Capital Markets Day 2017) shows 60% less churn when customers have committed to additional products such as smart home offerings and that customers in the highest value segment have a high propensity to hold multiple products and are 20% less likely to switch to another provider.
Stephen Phillips comments: “Partnering is an effective way for energy providers to keep up with the frenetic pace of change, to transform their customer facing services and to extend their reach into customers’ homes. But utilities need to pick their partners carefully. Thanks to our extensive experience, HomeServe understands the key elements of successful partnerships. Most important are alignment of culture, sharing the same values, and common vision and goals. HomeServe works with over 600 utility partners who understand and can deliver customer centric offerings, valuable benefits, ease of access, exceptional levels of service at the points of interaction and effective communications.”
HomeServe is an international home repairs and improvements business which provides people with access to tradespeople and technology to run their homes more easily. HomeServe is listed on the London Stock Exchange, with a market capitalisation of c. £3.2 billion. More information about HomeServe’s international partnership strategy can be found at www.homeserveglobal.com.
About Mitsubishi Corporation
Mitsubishi Corporation is a global integrated business enterprise that develops and operates businesses across virtually every industry, including industrial finance, energy, metals, machinery, chemicals and daily living essentials, having wide-ranging relationships with public and private utilities in Japan.
+44 7795 062564
+44 7970 840694
+44 207 353 4200
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
c-LEcta: Successful Product Business in the First Half of 201922.8.2019 11:06:00 EEST | Press release
c-LEcta, a globally active biotechnology company with technology leadership in enzyme engineering and bioprocess development, successfully expanded its product business in the first half of 2019. Besides sales increases across the entire portfolio, the company was granted many new patents. While the patent portfolio still comprised 59 granted patents at the end of the first half of 2018, the Leipzig-based company now holds more than 80 patents. c-LEcta’s DENARASE®, which is used for the necessary removal of nucleic acids from biopharmaceutical products, performed particularly well. DENARASE® is the most efficient technology on the market for meeting the stringent regulatory requirements for biopharmaceutical products. Sales of this product increased by 164% year-on-year in the first half of 2019. The other products in c-LEcta’s portfolio also performed very well and contributed to the positive development of the product business. c-LEcta now markets its self-developed products in 25 co
MobileIron Named a Leader Again in the Second Gartner Magic Quadrant for Unified Endpoint Management Tools22.8.2019 10:00:00 EEST | Press release
MobileIron (NASDAQ:MOBL), the company that introduced the industry’s first mobile-centric, zero trust platform for the enterprise, today announced that it has been positioned as a Leader for the second consecutive year in the Gartner Magic Quadrant for Unified Endpoint Management Tools. The report evaluated 11 vendors based on completeness of vision and ability to execute. “To us, it’s an honor to be recognized once again as a Leader in Gartner’s Magic Quadrant for Unified Endpoint Management Tools,” said Simon Biddiscombe, CEO, MobileIron. “We have continued to innovate and expand upon our UEM platform to keep up with the demands of today’s digital businesses. Earlier this year, we introduced a revolutionary zero sign-on experience to eliminate passwords and make the world’s most ubiquitous product – the mobile device – your ID and secure access to the enterprise built on our leadership foundation in UEM. Mobile and cloud technologies have driven a dramatic change in organizations acr
Miracor Medical Granted FDA Breakthrough Device Designation for the PiCSO Impulse System22.8.2019 09:00:00 EEST | Press release
Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO® Impulse System for treatment of STEMI patients. The FDA Breakthrough Device designation is intended to speed time to market for treatments of life-threatening or irreversibly debilitating diseases or conditions and recognizes the novelty of the PiCSO Impulse System and its potential to benefit patients with anterior STEMI heart attacks. The Centers for Medicare & Medicaid Services (CMS) also recently acknowledged the importance of this designation by establishing an alternative reimbursement pathway for products that receive FDA marketing authorization and held the Breakthrough Designation. PiCSO therapy is provided by interventional cardiologists during PCI (Percutaneous Coronary Intervention) in patients experiencing ST-elevated myocardial infarction (STEMI). The PiCSO Impulse System clears the coronary microcirculation by intermittently
Mori Building Unveils Massive Urban Regeneration Project in Central Tokyo22.8.2019 07:00:00 EEST | Press release
Mori Building Co., Ltd., a leading urban landscape developer, has begun construction on its “Toranomon-Azabudai District Category 1 Urban Redevelopment Project,” a massive urban regeneration project aimed at revitalizing a large area of central Tokyo. A groundbreaking ceremony was held on August 5 and project completion is scheduled for the end of March 2023. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190821005445/en/ Image of Office Lobby (Graphic: Business Wire) The core concept of the Toranomon-Azabudai Project is that of a “Modern Urban Village,” a unique neighborhood that will combine the sophistication of a megalopolis with the intimacy of a small village in the heart of Tokyo. It will cover an area of approximately 8.1 hectares, similar to that of New York’s Rockefeller Center, and will feature extensive greenery totaling 24,000 m2 including a 6,000 m2 central square. Total floor area will be 860,400 m2, including
Mundipharma Announces the Licence Extension Submission for Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin) to the European Medicines Agency22.8.2019 02:01:00 EEST | Press release
STRICTLY FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY As the European distributor of Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin), Mundipharma welcomes the news that the European Medicines Agency (EMA) has accepted the licence extension submission for these two medicines to treat stage 2 or stage 3 chronic kidney disease (CKD) and albuminuria as an adjunct to standard of care in adults with type 2 diabetes mellitus (T2DM). The submission is based on the results from the landmark Phase III CREDENCE study1 which evaluated the efficacy and safety of canagliflozin versus placebo in this high-risk patient population when used in addition to standard of care. “Chronic kidney disease is a serious complication of type 2 diabetes, which can increase patients’ risk of developing end-stage renal disease and may reduce their life expectancy by several years.” said Dr Vinicius Gomes de Lima, European Medical Affairs Lead, Mundipharma. “If approved, this licence
Triton Digital Releases Webcast Metrics Rankings for the Top Digital Audio Properties for April 201921.8.2019 23:00:00 EEST | Press release
Triton Digital®, the global technology and services leader to the digital audio and podcast industry, released today its monthly Webcast Metrics® rankers for April 2019. The global rankers, in addition to the U.S., LATAM, and EMEA regional rankers provide insight into the top-performing streaming audio stations and networks around the world for the month of April. The full results of the Global & Regional Rankers for April 2019 can be found here: https://www.tritondigital.com/resources/monthly-rankers/rankers-archive The Webcast Metrics streaming measurement service is the industry standard for online audio consumption data. It provides credible, validated data that enables audio publishers around the world to analyze the consumption of their audio content by daypart, device type, geography, distribution platform, and more. About Triton Digital Triton Digital® is the global technology and services leader to the digital audio and podcast industry. Operating in more than 40 countries, Tr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom